INmune Bio
INMB
37 hedge funds and large institutions have $14.5M invested in INmune Bio in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
12% more funds holding
Funds holding: 33 → 37 (+4)
0.67% more ownership
Funds ownership: 11.18% → 11.85% (+0.67%)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
20% less capital invested
Capital invested by funds: $18.2M → $14.5M (-$3.73M)
38% less call options, than puts
Call options by funds: $258K | Put options by funds: $416K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
Fermata Advisors
Sonoma,
California
|
+$470K |
| 2 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$317K |
| 3 |
Bank of New York Mellon
New York
|
+$273K |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$269K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$194K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$256K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$212K |
| 3 |
Renaissance Technologies
New York
|
-$182K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$92.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$86.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $29.1K | – | – | – |
|
27
Morgan Stanley
New York
| $27.6K | -$7.57K | -913 | -18% |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $17.2K | +$8.07K | +973 | +62% |
|
29
Wells Fargo
San Francisco,
California
| $16K | -$7.17K | -865 | -27% |
|
|
LSA
30
Leonteq Securities AG
Zurich,
Switzerland
| $10.9K | – | – | – |
|
|
VNA
31
Valley National Advisers
Bethlehem,
Pennsylvania
| $7K | – | – | – |
|
|
ADL
32
Asset Dedication LLC
San Francisco,
California
| $6K | – | – | – |
|
|
CA
33
Clearstead Advisors
Cleveland,
Ohio
| $5.69K | +$3.48K | +420 | +100% |
|
|
FDCDDQ
34
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2.71K | – | – | – |
|
|
IA
35
IFP Advisors
Tampa,
Florida
| $1.25K | – | – | – |
|
|
NS
36
NBC Securities
Birmingham,
Alabama
| $1K | +$2.24K | +270 | New |
|
37
Fidelity Investments
Boston,
Massachusetts
| $581 | – | – | – |
|
|
38
Millennium Management
New York
| – | -$256K | -28,146 | Closed |
|
|
39
Renaissance Technologies
New York
| – | -$182K | -20,000 | Closed |
|
INMB Hedge Fund Activity: Q3 2023 in Review
37 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q3 2023, worth a combined $14.5M — down 20% from $18.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new INMB positions and 3 closed out — a net gain of 4 holders — while 8 added to existing stakes and 9 trimmed.
The largest buyer was Fermata Advisors, opening a new position worth an estimated $470K. The largest seller was Millennium Management, exiting entirely with an estimated $256K sold.
- 37 institutional investors held INmune Bio (INMB) as of Q3 2023, up from 33 in Q2 2023.
- Funds reported $14.5M of INmune Bio stock for Q3 2023, down 20% quarter-over-quarter.
- 7 funds opened new INmune Bio positions in Q3 2023 and 3 closed out, a net change of +4 holders.
- The largest INmune Bio buyer in Q3 2023 was Fermata Advisors, an estimated $470K added.
- The largest INmune Bio seller in Q3 2023 was Millennium Management, an estimated $256K sold.
Based on aggregated 13F filings for Q3 2023.